C형 간염 바이러스 RNA 유무에 따른 지질, 인슐린저항성 및 대사증후군 지표 수준의 차이
Comparison of the Serum Cholesterol, Insulin Resistance and Markers of Metabolic Syndrome Based on Hepatitis C Virus RNA
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: We compared the difference of lipid, insulin resistance and metabolic markers based on HCV RNA in Korean adults. Methods: This was a cross-sectional study of 222 subjects visited the health promotion center of Pusan national university hospital from 2004 to 2007. Subjects were anti-HCV antibody positive and were performed RT-PCR for HCV RNA. The HCV RNA (+) group were 85 subjects, HCV RNA (-) control group were 115 subjects, and the HCV RNA (-) but past positive group were 22 subjects. We performed anthropometry, anti-HCV, RT-PCR, plasma concentrations of insulin, total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglyceride. Results: BMI, waist circumference, blood pressure, fasting plasma glucose, triglyceride, HDL cholesterol, insulin resistance such as HOMA-IR and QUICKI were not significantly different between HCV RNA positive and negative groups. The serum total cholesterol and LDL cholesterol level were significantly lower in the HCV RNA positive group than in the negative group (186.24±37.63 vs 197.22±37.23 mg/dl, p=0.041, 111.66±34.06 vs 121.38±35.50 mg/dl, p=0.042). After adjusting age and sex, high total cholesterol (≥ 200mg/dl) (adjusted OR=0.51, 95%CI 0.28- 0.94, p=0.03) and high LDL cholesterol (≥ 130mg/dl) (adjusted OR=0.46, 95%CI 0.24~0.87, p=0.02) were inversely associated with being HCV RNA positive (p<0.05). Conclusion: The serum total cholesterol and LDL-cholesterol level were significantly lower in HCV RNA (+) group than in HCV RNA (-) group, but not in HCV RNA (-) but past positive group. Prospective cohort studies are needed to clarify the relationship between HCV RNA and metabolic markers.
Abstract
Objectives: We compared the difference of lipid, insulin resistance and metabolic markers based on HCV RNA in Korean adults. Methods: This was a cross-sectional study of 222 subjects visited the health promotion center of Pusan national university hospital from 2004 to 2007. Subjects were anti-HCV antibody positive and were performed RT-PCR for HCV RNA. The HCV RNA (+) group were 85 subjects, HCV RNA (-) control group were 115 subjects, and the HCV RNA (-) but past positive group were 22 subjects. We performed anthropometry, anti-HCV, RT-PCR, plasma concentrations of insulin, total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglyceride. Results: BMI, waist circumference, blood pressure, fasting plasma glucose, triglyceride, HDL cholesterol, insulin resistance such as HOMA-IR and QUICKI were not significantly different between HCV RNA positive and negative groups. The serum total cholesterol and LDL cholesterol level were significantly lower in the HCV RNA positive group than in the negative group (186.24±37.63 vs 197.22±37.23 mg/dl, p=0.041, 111.66±34.06 vs 121.38±35.50 mg/dl, p=0.042). After adjusting age and sex, high total cholesterol (≥ 200mg/dl) (adjusted OR=0.51, 95%CI 0.28- 0.94, p=0.03) and high LDL cholesterol (≥ 130mg/dl) (adjusted OR=0.46, 95%CI 0.24~0.87, p=0.02) were inversely associated with being HCV RNA positive (p<0.05). Conclusion: The serum total cholesterol and LDL-cholesterol level were significantly lower in HCV RNA (+) group than in HCV RNA (-) group, but not in HCV RNA (-) but past positive group. Prospective cohort studies are needed to clarify the relationship between HCV RNA and metabolic markers.
참고문헌 (30)
- Memon MI, "Hepatitis C: an epidemiological review", J Viral Hepat, 9(2), pp.84~100 (2002)
- Shin HR, "Epidemiology of hepatitis C virus in Korea", Intervirology, 49(1-2), pp.18~22 (2006)
- 김명희, "C형 간염 바이러스 감염 진단을 위한 C형 간염 항체 ELISA검사와 C형 간염바이러스 역전사중합효소연쇄반응법의 유용성", Annals of Laboratory Medicine, 26(6), pp.418~423 (2006), 대한진단검사의학회
- 김영기, "3세대 Anti-HCV ELISA 검사의 진단 양성예측도 및 예측 인자-Anti-HCV ELISA Sample", Cutoff 비의 임상 의의를 중심으로-, 2005, pp.45(3), 181~188[DOI]
- Tashkandy MA, "Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection", Saudi J Kidney Dis Transpl, 18(4), pp.523~531 (2007)
- 박은옥, "제 5기 국민건강영양조사로 추정한 한국 성인의 대사증후군 유병률과 관련 요인", 농촌의학.지역보건, 38(1), pp.1~13 (2013), 한국농촌의학.지역보건학회
- Siagris D, "Serum lipid pattern in chronic hepatitis C: histological and virological correlations", J Viral Hepat, 13(1), pp.56~61 (2006)
- Dai CY, "Associations between hepatitis C viremia and low serum triglyceride andcholesterol levels: a community-based study", J Hepatol, 49(1), pp.9~16 (2008)
- Hsu CS, "Metabolic profiles in patients with chronic hepatitis C: a casecontrol study", Hepatol Int, 2(2), pp.250~257 (2008)
- Kathleen E. Corey, "Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term followup", Hepatology, 50(4), pp.1030~1037 (2009)
- Chen JY, "Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both Hepatitis B and C strains independently", Hepatology, 25(11), pp.1763~1768 (2010)
- 장재호, "정상인과 anti-HCV 양성자에서 인슐린 저항성의 유병률 비교", 대한내과학회지, 79(4), pp.381~386 (2010), 대한내과학회
- Ryu JK, "Association of chronic hepatitis C virus infection and diabetes mellitus in Korean Patients", Korean J Intern Med, 16(1), pp.18~23 (2001)
- Wilson C, "Hepatitis C infection and type 2 diabetes in American-Indian women", Diabetes Care, 27(9), pp.2116~2119 (2004)
- Lecube A, "High prevalence of glucose abnormalities in patients with hepatitis C virus infection", Diabetes Care, 27(5), pp.1171~1175 (2004)
- Huang JF1, "Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication", Am J Gastroenterol, 102(6), pp.1237~1243 (2007)
- Mohamed HR, "Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection", Int J Health Sci (Qassim), 3(2), pp.177~186 (2009)
- Jan CF, "A populationbased study investigating the association between metabolic syndrome and hepatitis B", C infection (Keelung Community-based Integrated Screening study No. 10), 2006, pp.30(5), 794~799
- Baizhanova ZhZh, "Metabolic syndrome and insulin resistance in patients with chronic hepatitis C", Ter Arkh, 82(10), pp.51~56 (2010)
- Matthews DR, "Homeostasis model assessment: insulin resistance and b cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28(7), pp.412~419 (1985)
- Katz A1, "Quantitative insulin sensitivity check index:a simple, accurate method for assessing insulin sensitivity in humans", J Clin Endocrinol Metab, 85(7), pp.2402~2410 (2000)
- Vanhala P, "The quantitative insulin sensitivity check index QUICKI predicts the onset of type 2 diabetes better than fasting plasma insulin in obese subjects: a five-year old follow-up study", J Clin Endocrinol Metab, 87(12), pp.5834~5837 (2002)
- Expert Panel on Ditection, Evaluation, and Treatment High Blood Cholesterol in Adults, "Executive Summary of the Third Report of the National Cholesterol Education Program(NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III)", JAMA, 285(19), pp.2486~2487 (2001)
- Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112(17), 2735~2752
- Lee SY, "Appropriate waist circumference cutoff points for central obesity in Korean adults", Diabetes Res Clin Pract, 75(1), pp.72~80 (2007)
- Amemiya F, "Targeting lipid metabolism in the treatment of hepatitis C virus infection", J Infect Dis, 197(3), pp.361~370 (2008)
- Lee CM, "Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications", Trans R Soc Trop Med Hyg, 100(8), pp.767~774 (2006)
- Nainan OV, "Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States", Gastroenterology, 131(2), pp.478~484 (2006)
- Raptopoulou M, "Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study", Hippokratia, 15(1), pp.26~31 (2011)
- Chen CH, "Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants", J Formos Med Assoc, 106(2), pp.148~155 (2007)